Cite
HARVARD Citation
Giordano, G. et al. (n.d.). Nab paclitaxel (Nab-P) and gemcitabine (G) first line chemotherapy (CT) in metastatic pancreatic cancer (mPC) patients (pts) relapsed after adjuvant treatment (ADJ T): A "real life" study. European journal of cancer. pp. S87-. [Online].